NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report

• Asıl Yazarlar: Jin Jiang (Yazar), Yikun Ren (Yazar), Chengping Xu (Yazar), Xing Lin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2022-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background NUT (nuclear protein in testis) midline carcinoma (NMC) is a rapidly progressive tumor arising from midline structures. Recent cases have reported that the poor prognosis with a median survival of 6.7 months and a 2 years overall survival of 19% due to limited treatment. Based on...